Trenbolone 'recovery protocols': what the evidence actually says

What did @adaclipsadmin actually say?

The creator described a case study of a man who used trenbolone at 300mg per week, developed erectile dysfunction after two months, stopped abruptly, then spiraled into a "very bad depression" during a two-month withdrawal period. The proposed recovery protocol combined sertraline for depression and cabergoline to "mitigate the suffering." The creator flagged CNS effects, hypersexuality, night sweats, panic attacks, and personality changes as the most significant side effects, and raised whether these changes are permanent, concluding permanent damage is rare but recovery "could be months even on testosterone."

Does the science back this up?

Mostly yes, with real gaps worth naming. Trenbolone is a 19-nor synthetic androgen with roughly four to five times the androgenic potency of testosterone, and its CNS and psychiatric effects are among the most consistently documented in the steroid literature. Pope et al. (2014, Drug and Alcohol Dependence) documented significant rates of hypogonadism, mood disturbance, and libido dysfunction following supraphysiologic androgen use and cessation. The ED claim after abrupt cessation is also well-supported. Trenbolone does not aromatize but acts as a strong progestin, suppressing the HPG axis aggressively. When stopped suddenly, the resulting androgen crash combined with elevated prolactin-adjacent signaling creates exactly the dysfunction described. The cabergoline use as a dopaminergic agent to support mood and libido recovery is mechanistically plausible but lacks RCT evidence in this specific context. Fragkaki et al. (2009, Steroids) confirmed trenbolone's potent HPG suppression. Kanayama et al. (2015, Drug and Alcohol Dependence) linked long-term AAS use to dependence and mood disorders.

What did they get wrong or right?

The creator gets credit for saying trenbolone "seems to change men." That is not hyperbole. That tracks with the research. Where it gets shaky is the protocol endorsement. Describing a dual-drug recovery approach as "brilliant" based on a single patient's self-report is not evidence. That is a case report of one. Cabergoline is approved for hyperprolactinemia and Parkinson's disease. Its off-label use here rests on dopamine-libido mechanistic logic, not clinical trial data. Presenting it as a validated protocol is an overreach. Also, abrupt trenbolone cessation without any bridging hormone support deserved more critical framing than it received. The creator implies the abrupt stop was simply what happened, without flagging that managed tapers or bridging protocols are commonly discussed in harm reduction literature for exactly this reason.

What should you actually know?

Trenbolone was never approved for human use. It is a veterinary compound. Anyone using it is operating entirely outside regulated medicine, which means recovery from its side effects also happens outside established protocols. Rahnema et al. (2014, Fertility and Sterility) confirmed that anabolic steroid-induced hypogonadism can persist for years in some users even with intervention. The psychiatric effects are real and can be serious. If you are experiencing depression, panic attacks, or sexual dysfunction after stopping any anabolic steroid, that requires evaluation by a licensed physician, not a social media protocol. Sertraline has a legitimate evidence base for major depressive episodes and its use here is clinically defensible under supervised care. Cabergoline is a real drug with real risks including cardiac valvulopathy with long-term use, and should not be self-administered based on a TikTok case report.